Equities analysts predict that Perrigo Company PLC (NYSE:PRGO) will announce $1.18 billion in sales for the current fiscal quarter, Zacks reports. Eight analysts have made estimates for Perrigo’s earnings. The highest sales estimate is $1.23 billion and the lowest is $1.15 billion. Perrigo reported sales of $1.22 billion in the same quarter last year, which indicates a negative year-over-year growth rate of 3.3%. The company is expected to report its next earnings results on Tuesday, May 14th.

On average, analysts expect that Perrigo will report full-year sales of $4.74 billion for the current financial year, with estimates ranging from $4.60 billion to $4.82 billion. For the next financial year, analysts anticipate that the company will report sales of $4.82 billion, with estimates ranging from $4.61 billion to $4.90 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that that provide coverage for Perrigo.

Perrigo (NYSE:PRGO) last released its quarterly earnings data on Wednesday, February 27th. The company reported $0.97 EPS for the quarter, missing the Zacks’ consensus estimate of $1.00 by ($0.03). The business had revenue of $1.20 billion during the quarter, compared to analyst estimates of $1.18 billion. Perrigo had a net margin of 2.77% and a return on equity of 10.74%. The firm’s revenue was down 6.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.28 EPS.

A number of analysts have recently issued reports on the stock. ValuEngine upgraded shares of Perrigo from a “sell” rating to a “hold” rating in a report on Wednesday, December 5th. SunTrust Banks assumed coverage on shares of Perrigo in a report on Tuesday, March 19th. They set a “hold” rating and a $51.00 price target for the company. Royal Bank of Canada set a $48.00 price target on shares of Perrigo and gave the stock a “hold” rating in a report on Thursday, February 28th. Wells Fargo & Co set a $47.00 price target on shares of Perrigo and gave the stock a “hold” rating in a report on Thursday, February 28th. Finally, Morgan Stanley cut their price target on shares of Perrigo from $67.00 to $54.00 and set an “equal weight” rating for the company in a report on Tuesday. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have given a buy rating to the company. Perrigo currently has a consensus rating of “Hold” and a consensus target price of $74.67.

Shares of NYSE PRGO opened at $47.83 on Thursday. The company has a market cap of $6.35 billion, a PE ratio of 10.51, a PEG ratio of 2.12 and a beta of 1.31. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.89 and a quick ratio of 1.32. Perrigo has a 1 year low of $36.28 and a 1 year high of $84.94.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Friday, March 1st were given a dividend of $0.19 per share. The ex-dividend date was Thursday, February 28th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.59%. Perrigo’s payout ratio is currently 16.70%.

Several large investors have recently bought and sold shares of the stock. Geode Capital Management LLC boosted its position in shares of Perrigo by 12.4% during the 4th quarter. Geode Capital Management LLC now owns 1,687,709 shares of the company’s stock worth $65,286,000 after purchasing an additional 186,095 shares during the period. Norges Bank purchased a new position in shares of Perrigo during the 4th quarter worth approximately $44,386,000. Kentucky Retirement Systems purchased a new position in shares of Perrigo during the 4th quarter worth approximately $211,000. Macquarie Group Ltd. boosted its position in shares of Perrigo by 58.8% during the 4th quarter. Macquarie Group Ltd. now owns 372,200 shares of the company’s stock worth $14,423,000 after purchasing an additional 137,800 shares during the period. Finally, Covington Capital Management purchased a new position in shares of Perrigo during the 4th quarter worth approximately $46,000. 85.29% of the stock is owned by hedge funds and other institutional investors.

About Perrigo

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.

Featured Story: Intrinsic Value

Get a free copy of the Zacks research report on Perrigo (PRGO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.